ULTRASONIC IMAGING, published by SAGE PUBLICATIONS INC, is a leading journal within the fields of Radiology, Nuclear Medicine, and Imaging, with a particular focus on advancing the science and application of ultrasound technology. Since its inception in 1979, the journal has provided a platform for high-quality research, featuring innovative studies that bridge theoretical advancements and practical applications, making it an essential resource for researchers and professionals. With a notable impact factor reflecting its robust contribution to the medical community (2023: Q2 rankings in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine, and Imaging), ULTRASONIC IMAGING serves to disseminate pivotal developments in diagnostic imaging techniques, enhancing the understanding of ultrasound's role in patient care. Researchers are encouraged to explore this journal's collection of cutting-edge articles that push the boundaries of knowledge in ultrasound imaging and its implementation in clinical practices.

RADIOLOGY, published by the Radiological Society of North America (RSNA), stands as a premier journal in the fields of radiology, nuclear medicine, and imaging. Established in 1945, this esteemed journal has consistently provided groundbreaking research and insights, helping to shape advancements in diagnostic imaging and therapeutic interventions. With a commendable Q1 ranking in its category and a remarkable 99th percentile ranking in Scopus, RADIOLOGY continues to be a pivotal resource for clinicians, researchers, and students alike. Although not an Open Access journal, it offers a wealth of high-quality peer-reviewed articles that contribute significantly to the ongoing discourse in the medical community. With a strong focus on innovative techniques and the integration of new technologies, RADIOLOGY remains essential for professionals aiming to stay at the forefront of medical imaging practices.

World Journal of Nuclear Medicine, published by THIEME MEDICAL PUBL INC, is a premier peer-reviewed journal dedicated to advancing the field of nuclear medicine. With an Open Access model established since 2011, this journal ensures that high-quality research is accessible to a wide audience, fostering knowledge sharing and collaboration among researchers, clinicians, and students alike. The journal aims to publish innovative studies, reviews, and clinical trials that contribute significantly to both the theoretical and practical aspects of nuclear medicine, enhancing diagnostic and therapeutic techniques within this critical area of healthcare. As the journal continues to grow in visibility and impact, it remains an essential resource for those seeking to stay at the forefront of advancements in nuclear medicine.

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.

Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.

The European Journal of Radiology, published by Elsevier Ireland Ltd, is a premier peer-reviewed journal in the fields of radiology, nuclear medicine, and imaging. Established in 1981, it has carved a significant niche within the academic community, showcasing innovative research that enhances medical imaging practices and improves patient care. With an impressive ranking in the Q1 category for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging in 2023, the journal is recognized globally for its commitment to advancing scientific knowledge and improving imaging methodologies. The journal's Scopus ranking of #60/333, placing it in the 82nd percentile, underlines its reputation for high-quality research and scholarly contributions. While traditionally a subscription-based journal, it continually evolves to meet the demands of the academic landscape, aiming to bridge the gap between research and clinical practice. Researchers, healthcare professionals, and students alike can benefit from exploring its extensive archives and current publications, which are curated to foster education and innovation in the medical imaging domain.

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.